发明名称 |
Tumoricidal, bactericidal, or viricidal macrophage activation |
摘要 |
The activation of macrophages and methods for treating cancer, bacterial pathogens and viral pathogens are disclosed. In particular, Gc protein is converted to Gc-macrophage activating factor (GcMAF), or . The GcMAF activates macrophages which can then target cancer cells, bacterial pathogens and/or viral pathogens. Alternatively, macrophages are activated by contacting them, or, with GcMAF. Optionally, nagalase is inactivated in a patient receiving the present macrophage activating treatment by contacting the patient's blood with a Nagalase-binding ligand immobilized on an inert medium. |
申请公布号 |
AU2010289901(A1) |
申请公布日期 |
2012.03.15 |
申请号 |
AU20100289901 |
申请日期 |
2010.08.23 |
申请人 |
SILVETZ, ROBERT;KNEZEVICH, CHARLES |
发明人 |
KNEZEVICH, CHARLES;SILVETZ, ROBERT |
分类号 |
C07K14/47;A61K38/17;A61K47/30;A61K47/38;A61K47/48;A61P31/00;A61P35/00 |
主分类号 |
C07K14/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|